242 related articles for article (PubMed ID: 23400519)
1. Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin A.
Tran HT; Kim HN; Lee IK; Nguyen-Pham TN; Ahn JS; Kim YK; Lee JJ; Park KS; Kook H; Kim HJ
J Korean Med Sci; 2013 Feb; 28(2):237-46. PubMed ID: 23400519
[TBL] [Abstract][Full Text] [Related]
2. Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition.
Lakshmikuttyamma A; Scott SA; DeCoteau JF; Geyer CR
Oncogene; 2010 Jan; 29(4):576-88. PubMed ID: 19881540
[TBL] [Abstract][Full Text] [Related]
3. Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia.
Zou Y; Ma X; Huang Y; Hong L; Chiao JW
J Hematol Oncol; 2012 Jul; 5():36. PubMed ID: 22747680
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.
Wu LP; Wang X; Li L; Zhao Y; Lu S; Yu Y; Zhou W; Liu X; Yang J; Zheng Z; Zhang H; Feng J; Yang Y; Wang H; Zhu WG
Mol Cell Biol; 2008 May; 28(10):3219-35. PubMed ID: 18332107
[TBL] [Abstract][Full Text] [Related]
5. The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells.
Lai YS; Chen JY; Tsai HJ; Chen TY; Hung WC
Blood Cancer J; 2015 May; 5(5):e313. PubMed ID: 25978433
[TBL] [Abstract][Full Text] [Related]
6. Effects of histone methyltransferase inhibitor chaetocin on histone H3K9 methylation of cultured ovine somatic cells and development of preimplantation cloned embryos.
Zhang YM; Gao EE; Wang QQ; Tian H; Hou J
Reprod Toxicol; 2018 Aug; 79():124-131. PubMed ID: 29909068
[TBL] [Abstract][Full Text] [Related]
7. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.
Fiskus W; Wang Y; Sreekumar A; Buckley KM; Shi H; Jillella A; Ustun C; Rao R; Fernandez P; Chen J; Balusu R; Koul S; Atadja P; Marquez VE; Bhalla KN
Blood; 2009 Sep; 114(13):2733-43. PubMed ID: 19638619
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A.
Ninios YP; Sekeri-Pataryas KE; Sourlingas TG
Leuk Res; 2010 Jun; 34(6):786-92. PubMed ID: 19782399
[TBL] [Abstract][Full Text] [Related]
10. The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response.
Bernhard W; Barreto K; Saunders A; Dahabieh MS; Johnson P; Sadowski I
FEBS Lett; 2011 Nov; 585(22):3549-54. PubMed ID: 22020221
[TBL] [Abstract][Full Text] [Related]
11. Anti-leukemic effects of HDACi Belinostat and HMTi 3-Deazaneplanocin A on human acute promyelocytic leukemia cells.
Valiulienė G; Stirblytė I; Jasnauskaitė M; Borutinskaitė V; Navakauskienė R
Eur J Pharmacol; 2017 Mar; 799():143-153. PubMed ID: 28192098
[TBL] [Abstract][Full Text] [Related]
12. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression.
Scott SA; Lakshimikuttysamma A; Sheridan DP; Sanche SE; Geyer CR; DeCoteau JF
Exp Hematol; 2007 Feb; 35(2):263-73. PubMed ID: 17258075
[TBL] [Abstract][Full Text] [Related]
13. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
[TBL] [Abstract][Full Text] [Related]
14. Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism.
Fang S; Miao J; Xiang L; Ponugoti B; Treuter E; Kemper JK
Mol Cell Biol; 2007 Feb; 27(4):1407-24. PubMed ID: 17145766
[TBL] [Abstract][Full Text] [Related]
15. Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2'-deoxycytidine alters their growth characteristics, gene expression and epigenetic status and improves the in vitro developmental competence, quality and epigenetic status of cloned embryos.
Saini M; Selokar NL; Agrawal H; Singla SK; Chauhan MS; Manik RS; Palta P
Reprod Fertil Dev; 2016 Apr; 28(6):824-37. PubMed ID: 25409339
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.
Shaker S; Bernstein M; Momparler LF; Momparler RL
Leuk Res; 2003 May; 27(5):437-44. PubMed ID: 12620295
[TBL] [Abstract][Full Text] [Related]
17. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
Chen J; Du C; Kang J; Wang J
Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528
[TBL] [Abstract][Full Text] [Related]
18. Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1.
Chaib H; Nebbioso A; Prebet T; Castellano R; Garbit S; Restouin A; Vey N; Altucci L; Collette Y
Leukemia; 2012 Apr; 26(4):662-74. PubMed ID: 21979880
[TBL] [Abstract][Full Text] [Related]
19. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines.
Ma J; Guo X; Zhang S; Liu H; Lu J; Dong Z; Liu K; Ming L
Mol Med Rep; 2015 Jun; 11(6):4525-31. PubMed ID: 25634603
[TBL] [Abstract][Full Text] [Related]
20. High Glucose Increases the Expression of Inflammatory Cytokine Genes in Macrophages Through H3K9 Methyltransferase Mechanism.
Li MF; Zhang R; Li TT; Chen MY; Li LX; Lu JX; Jia WP
J Interferon Cytokine Res; 2016 Jan; 36(1):48-61. PubMed ID: 26406561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
